文献速递肾移植

人肾来源造血干细胞可支持长期多系造血

Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis.
PubMed 文献 · Kidney Int · 2022-09-13

一例合并综合征型联合免疫缺陷的儿童肾移植受者出现超过99%的多系供者来源造血嵌合,供者T细胞为移植物来源造血干细胞腾出骨髓空间,人肾来源造血干细胞长期定居受者骨髓并逐渐替代宿主对应细胞,导致血型转换及淋巴系和髓系完全供者嵌合。

要点

  • 儿童肾移植受者出现超过99%的多系供者来源造血嵌合。
  • 人肾来源造血干细胞长期定居受者骨髓并逐渐替代宿主对应细胞。
  • 供者T细胞通过为移植物来源造血干细胞腾出骨髓空间促进植入。

核心结论

  • 人肾来源造血干细胞具有自我更新能力,能够支持多系造血。

研究设计与样本

  • 本文为病例报告,对象为一例合并综合征型联合免疫缺陷的儿童肾移植受者。

主要发现

  • 该受者出现超过99%的多系供者来源造血嵌合。
  • 人肾来源造血干细胞长期定居于受者骨髓并逐渐替代宿主对应细胞。
  • 上述过程导致血型转换以及淋巴系和髓系完全供者嵌合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long-term multilineage hematopoietic donor chimerism occurs sporadically in patients who receive a transplanted solid organ enriched in lymphoid tissues such as the intestine or liver. There is currently no evidence for the presence of kidney-resident hematopoietic stem cells in any mammal species. Graft-versus-host-reactive donor T cells promote engraftment of graft-derived hematopoietic stem cells by making space in the bone marrow. Here, we report full (over 99%) multilineage, donor-derived hematopoietic chimerism in a pediatric kidney transplant recipient with syndromic combined immune deficiency that leads to transplant tolerance. Interestingly, we found that the human kidney-derived hematopoietic stem cells took up long-term residence in the recipient's bone marrow and gradually replaced their host counterparts, leading to blood type conversion and full donor chimerism of both lymphoid and myeloid lineages. Thus, our findings highlight the existence of human kidney-derived hematopoietic stem cells with a self-renewal ability able to support multilineage hematopoiesis.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Sobrino S, Abdo C, Neven B, et al. Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis. Kidney Int. 2022. PMID: 36108807. doi:10.1016/j.kint.2022.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。